ArticleEuropean heart journal. Case reports2026
Incomplete Kawasaki disease with multivessel giant coronary aneurysms and refractory thrombosis in an infant; a case report.
Article in European heart journal. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Triple-vessel coronary involvement and giant aneurysm in a 6-year-old boy with kawasaki disease: a case report.BMC cardiovascular disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Kawasaki disease (KD) is an acute vasculitis of childhood with risk of coronary artery aneurysm (CAA) formation. Giant CAAs, thrombosis, and the need for revascularization in infancy are uncommon and clinically challenging. Case summary: A 9-month-old infant presented with persistent fever for 3 weeks before diagnosis and incomplete KD features. Echocardiography and computed tomographic coronary angiography revealed multivessel giant CAAs involving the left anterior descending (LAD), right coronary artery, and left circumflex (LCX) arteries, with multiple thrombi and a left atrial appendage thrombus. Alteplase was given in the intensive care unit for three cycles without thrombus resolution. A catheter-based attempt to recanalize the occluded LCX was unsuccessful. The patient was discharged on triple therapy with aspirin, clopidogrel, and rivaroxaban. Discussion: This case highlights the consequences of delayed recognition of incomplete KD, the limited efficacy of thrombolysis with alteplase in coronary thrombosis secondary to KD, the technical limitations and uncertain durability of percutaneous coronary intervention (PCI) in KD-related lesions during infancy, and evolving antithrombotic strategies, including the emerging role of direct oral anticoagulants for giant CAAs. Conclusion: Earlier diagnosis and risk-stratified therapy are essential to mitigate CAA complications. When revascularization and thrombolysis are not feasible or unsuccessful, individualized combinations of double antiplatelet and anticoagulant therapy may reduce thrombotic risk, necessitating close multidisciplinary follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.